제약용 생성형 인공지능(AI) 시장 보고서(2026년)

Generative artificial intelligence (AI) in the pharmaceutical industry utilizes advanced algorithms and machine learning to design new drug compounds, predict molecular behaviors, and streamline drug discovery. It employs techniques such as deep learning and generative adversarial networks (GANs) to create novel molecular structures and simulate their interactions.

Generative AI in pharmaceuticals primarily focuses on two types of molecules such as small molecules and large molecules. Small-molecule drugs are low-molecular-weight compounds that can easily penetrate cells and influence biological processes. Technologies involved include deep learning, natural language processing, querying methods, and context-aware processing, which are applied in areas such as clinical trial research, drug discovery, and research and development.

Tariffs have impacted the pharmaceutical generative AI market by increasing costs for importing advanced computational hardware, specialized laboratory equipment, and chemical reagents necessary for drug discovery. The rise in import duties has affected segments such as small molecule drug discovery and biologics development, particularly in regions heavily reliant on imports from North America and Asia. While tariffs have created cost pressures and slowed adoption in some research hubs, they have also encouraged local manufacturing and innovation, driving companies to develop more cost-efficient AI platforms and localized supply chains.

The generative artificial intelligence (AI) in pharmaceutical market research report is one of a series of new reports from The Business Research Company that provides generative artificial intelligence (AI) in pharmaceutical market statistics, including generative artificial intelligence (AI) in pharmaceutical industry global market size, regional shares, competitors with a generative artificial intelligence (AI) in pharmaceutical market share, detailed generative artificial intelligence (AI) in pharmaceutical market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (AI) in pharmaceutical industry. This generative artificial intelligence (AI) in pharmaceutical market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The generative artificial intelligence (AI) in pharmaceutical market size has grown exponentially in recent years. It will grow from $2.43 billion in 2025 to $3.19 billion in 2026 at a compound annual growth rate (CAGR) of 31.2%. The growth in the historic period can be attributed to increasing r&d investments in pharmaceuticals, rise in chronic diseases, growing adoption of AI in early-stage drug discovery, expansion of biologics market, availability of large-scale molecular datasets.

The generative artificial intelligence (AI) in pharmaceutical market size is expected to see exponential growth in the next few years. It will grow to $9.36 billion in 2030 at a compound annual growth rate (CAGR) of 30.9%. The growth in the forecast period can be attributed to advancements in generative AI algorithms, growth of precision medicine, expansion of virtual clinical trials, rising demand for biologics optimization, integration of AI with cloud computing. Major trends in the forecast period include AI-driven drug design optimization, predictive molecular modeling, virtual screening of compound libraries, personalized medicine development, biopharmaceutical efficacy simulation.

The increasing focus on personalized medicine is expected to support the growth of generative artificial intelligence (AI) in the pharmaceutical market going forward. Personalized medicine customizes medical treatment based on individual patient characteristics, including genetic, environmental, and lifestyle factors. The emphasis on personalized medicine is growing due to advancements in genetic research and medical technologies, enabling more precise and effective therapies tailored to individual needs. Personalized medicine utilizes generative AI in pharmaceuticals to design customized drug therapies, improving treatment effectiveness and patient outcomes. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for rare disease patients in 2023, compared with six approvals in 2022. Therefore, the increasing focus on personalized medicine is contributing to the growth of generative artificial intelligence (AI) in the pharmaceutical market.

Leading companies operating in the generative artificial intelligence (AI) in pharmaceutical market are developing new products, such as AI healthcare microservices, to accelerate drug discovery workflows. AI healthcare microservices are modular, cloud-based services that apply artificial intelligence to functions including drug discovery, diagnostics, and genomics. For example, in March 2024, Nvidia Corporation, a US-based technology company, launched generative AI microservices featuring optimized NIM AI models and APIs for cloud-native application development. These microservices support imaging, language processing, speech recognition, and digital biology, enhancing drug discovery and genomics research efficiency.

In June 2023, Eli Lilly and Company, a US-based pharmaceutical and biomedical research company, collaborated with XtalPi Inc. This partnership will utilize XtalPi's advanced AI-driven drug discovery platform, ID4Inno, to design and develop drug candidates targeting a specific, undisclosed objective. The collaboration leverages XtalPi's technology to explore large chemical spaces and identify promising candidates through iterative design, synthesis, testing, and analysis, supported by autonomous robotic systems to ensure efficiency and precision. XtalPi Inc. is a China-based AI-powered drug research and development company.

Major companies operating in the generative artificial intelligence (AI) in pharmaceutical market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc., Numerate Inc., Atomwise Inc., BenevolentAI Limited

North America was the largest region in the generative artificial intelligence (AI) in the pharmaceutical market in 2025. The regions covered in the generative artificial intelligence (AI) in pharmaceutical market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the generative artificial intelligence (AI) in pharmaceutical market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative artificial intelligence (AI) in pharmaceutical market includes revenues earned by entities through drug design, clinical trial optimization, biomarker discovery, and virtual screening. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generative Artificial Intelligence (AI) In Pharmaceutical Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses generative artificial intelligence (AI) in pharmaceutical market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generative artificial intelligence (AI) in pharmaceutical ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The generative artificial intelligence (AI) in pharmaceutical market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Small Molecule; Large Molecule
• 2) By Technology: Deep Learning; Natural Language Processing; Querying Method; Context-Aware Processing; Other Technologies
• 3) By Application: Clinical Trial Research; Drug Discovery; Research And Development; Other Applications
• Subsegments:
• 1) By Small Molecule: Drug Discovery And Design; Lead Optimization For Small Molecule Compounds; Predictive Modeling For Pharmacokinetics And Toxicity; Virtual Screening Of Compound Libraries; Personalized Medicine Approaches For Small Molecule Therapies
• 2) By Large Molecule: Biologics Discovery And Development; Monoclonal Antibody Design; Protein Engineering And Optimization; Vaccine Development And Optimization; Predictive Models For Biopharmaceutical Efficacy And Safety.
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca PLC; Novartis AG; GlaxoSmithKline plc; Fujitsu Limited; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Amgen Inc.; Gilead Sciences Inc.; NVIDIA Corporation; Conduent Incorporated; XtalPi Inc.; Insilico Medicine Inc.; Numerate Inc.; Atomwise Inc.; BenevolentAI Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Generative Artificial Intelligence (AI) In Pharmaceutical Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Generative Artificial Intelligence (AI) In Pharmaceutical Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Autonomous Systems, Robotics & Smart Mobility
• 4.2. Major Trends
  • 4.2.1 AI-Driven Drug Design Optimization
  • 4.2.2 Predictive Molecular Modeling
  • 4.2.3 Virtual Screening Of Compound Libraries
  • 4.2.4 Personalized Medicine Development
  • 4.2.5 Biopharmaceutical Efficacy Simulation

5. Generative Artificial Intelligence (AI) In Pharmaceutical Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biotechnology Firms
• 5.3 Contract Research Organizations (Cros)
• 5.4 Academic & Research Institutions
• 5.5 Hospitals & Clinical Research Centers

6. Generative Artificial Intelligence (AI) In Pharmaceutical Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Generative Artificial Intelligence (AI) In Pharmaceutical Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Generative Artificial Intelligence (AI) In Pharmaceutical Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Generative Artificial Intelligence (AI) In Pharmaceutical Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Generative Artificial Intelligence (AI) In Pharmaceutical Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Generative Artificial Intelligence (AI) In Pharmaceutical Market Segmentation

• 9.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Small Molecule, Large Molecule
• 9.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Deep Learning, Natural Language Processing, Querying Method, Context-Aware Processing, Other Technologies
• 9.3. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Clinical Trial Research, Drug Discovery, Research And Development, Other Applications
• 9.4. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Drug Discovery And Design, Lead Optimization For Small Molecule Compounds, Predictive Modeling For Pharmacokinetics And Toxicity, Virtual Screening Of Compound Libraries, Personalized Medicine Approaches For Small Molecule Therapies
• 9.5. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biologics Discovery And Development, Monoclonal Antibody Design, Protein Engineering And Optimization, Vaccine Development And Optimization, Predictive Models For Biopharmaceutical Efficacy And Safety

10. Generative Artificial Intelligence (AI) In Pharmaceutical Market, Industry Metrics By Country

• 10.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
• 10.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Generative Artificial Intelligence (AI) In Pharmaceutical Market Regional And Country Analysis

• 11.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 11.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 12.1. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 13.1. China Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 13.2. China Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 14.1. India Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 15.1. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 15.2. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 16.1. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 17.1. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 18.1. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 19.1. Taiwan Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. Taiwan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 20.1. South East Asia Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. South East Asia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 21.1. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 21.2. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 22.1. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 23.1. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 24.1. France Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 25.1. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 26.1. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 27.1. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 27.2. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 28.1. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 29.1. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 30.1. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 31.1. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 32.1. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 32.2. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 33.1. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 34.1. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 35.1. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 35.2. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Generative Artificial Intelligence (AI) In Pharmaceutical Market Regulatory and Investment Landscape

37. Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Landscape And Company Profiles

• 37.1. Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Landscape And Market Share 2024
  • 37.1.1. Top 10 Companies (Ranked by revenue/share)
• 37.2. Generative Artificial Intelligence (AI) In Pharmaceutical Market - Company Scoring Matrix
  • 37.2.1. Market Revenues
  • 37.2.2. Product Innovation Score
  • 37.2.3. Brand Recognition
• 37.3. Generative Artificial Intelligence (AI) In Pharmaceutical Market Company Profiles
  • 37.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

38. Generative Artificial Intelligence (AI) In Pharmaceutical Market Other Major And Innovative Companies

• Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc.

39. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Benchmarking And Dashboard

40. Key Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Pharmaceutical Market

41. Generative Artificial Intelligence (AI) In Pharmaceutical Market High Potential Countries, Segments and Strategies

• 41.1. Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2030 - Countries Offering Most New Opportunities
• 41.2. Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2030 - Segments Offering Most New Opportunities
• 41.3. Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2030 - Growth Strategies
  • 41.3.1. Market Trend Based Strategies
  • 41.3.2. Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer